Industry and Geographic Information

9 Months Ended

Sep. 30, 2019

Industry And Geographic Information [Abstract]

Industry and Geographic Information

Industry and Geographic Information

The Company operates in one reportable segment. Sales to customers outside the U.S. represented $129.0 million (34%) and $124.3 million (32%) of total revenue for the nine months ended September 30, 2019 and 2018, respectively. As of September 30, 2019 and December 31, 2018, accounts receivable due from foreign customers were $19.8 million and $23.4 million, respectively.

The Company had sales to individual customers in excess of 10% of total revenues, as follows:

	Nine Months Ended September 30,
	2019		2018
Customer:
A	17	%	17	%
B	15	%	14	%
C	13	%	12	%
Total:	45	%	43	%

As of September 30, 2019 and December 31, 2018, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $51.7 million and $33.3 million, respectively.

Consolidated total revenues by product category for the three and nine months ended September 30, 2019 and 2018 were as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2019		2018		2019		2018
Rapid Immunoassay	$	42,534	$	35,366	$	126,800	$	132,740
Cardiac Immunoassay	66,820		65,287		200,674		203,581
Specialized Diagnostic Solutions	12,455		12,294		40,595		39,859
Molecular Diagnostic Solutions	4,683		4,452		14,643		13,517
Total revenues	$	126,492	$	117,399	$	382,712	$	389,697